News & Press: Latest News

MDMA Statement on Scott Gottlieb’s Confirmation as the Next FDA Commissioner

Tuesday, May 9, 2017  
Share |

MDMA Statement on Scott Gottlieb’s Confirmation as the Next FDA Commissioner


WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the Senate confirmation of Dr. Scott Gottlieb as the next Commissioner of the Food and Drug Administration (FDA):


“MDMA congratulates Dr. Gottlieb on his confirmation as the next FDA Commissioner and looks forward to working with him to achieve our common goals of improving patient care and spurring medical technology innovation. 


“While the regulatory environment has improved over the years, we know that there is more work to do to establish reasonable and predictable pathways for the next generation of medical devices.  Patients and providers continue to search for solutions to the pressing needs facing the health care system, and med tech innovators are working to develop the cures and therapies that they desperately need. 


“MDMA and our members are committed to working closely with Dr. Gottlieb to ensure that the United States remains the global leader in medical technology innovation, and that our industry can build upon our proud track record of alleviating human suffering and saving lives.”